These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3028550)

  • 1. The effects of N-(cyclopropylmethyl)-19-isopentylnororvinol (M320), a potent agonist at kappa- and mu-opiate receptors, on urine excretion of rats.
    Abrahams JM; Boura AL; Evans RG; Johnston CI; Olley JE
    Br J Pharmacol; 1986 Dec; 89(4):759-67. PubMed ID: 3028550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the effects of subacute treatment with N-(cyclopropylmethyl)-19-isopentylnororvinol (M320) on timing of parturition in the rat.
    Evans RG; Rice GE; Olley JE
    Br J Pharmacol; 1988 Nov; 95(3):777-82. PubMed ID: 3207993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
    Vaupel DB; Cone EJ; Johnson RE; Su TP
    J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mu- and K-opiate receptor agonists reduce plasma neurohypophysial hormone concentrations in water-deprived and normally hydrated rats.
    Evans RG; Olley JE; Rice GE; Abrahams JM
    Clin Exp Pharmacol Physiol; 1989 Mar; 16(3):191-7. PubMed ID: 2541954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diuresis and suppression of vasopressin by kappa opioids: comparison with mu and delta opioids and clonidine.
    Leander JD; Zerbe RL; Hart JC
    J Pharmacol Exp Ther; 1985 Aug; 234(2):463-9. PubMed ID: 2991502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of TAPP, a highly selective mu-opioid agonist.
    Gutkowska J; Schiller PW
    Br J Pharmacol; 1996 Sep; 119(2):239-44. PubMed ID: 8886404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the opioid activity of CAM and kappa agonists.
    Furst S; Friedmann T; Kovacs A; Wagner T
    NIDA Res Monogr; 1986; 75():224-7. PubMed ID: 2828975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective cardiovascular and neuroendocrine effects of a kappa-opioid agonist in the nucleus tractus solitarii of rats.
    Carter DA; Lightman SL
    J Physiol; 1985 Oct; 367():363-75. PubMed ID: 2997441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels.
    Leander JD; Hart JC; Zerbe RL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):33-9. PubMed ID: 3039112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man.
    Pfeiffer A; Knepel W; Braun S; Meyer HD; Lohmann H; Brantl V
    Horm Metab Res; 1986 Dec; 18(12):842-8. PubMed ID: 3028922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
    Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
    J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
    Salas SP; Roblero J; Ureta H; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):992-9. PubMed ID: 2550625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.
    Rogers H; Birch PJ; Harrison SM; Palmer E; Manchee GR; Judd DB; Naylor A; Scopes DI; Hayes AG
    Br J Pharmacol; 1992 Aug; 106(4):783-9. PubMed ID: 1327387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of vasopressin in regulation of renal kinin excretion in Long-Evans and diabetes insipidus rats.
    Kauker ML; Crofton JT; Share L; Nasjletti A
    J Clin Invest; 1984 Mar; 73(3):824-31. PubMed ID: 6561201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A series of novel, highly potent and selective agonists for the kappa-opioid receptor.
    Hayes AG; Birch PJ; Hayward NJ; Sheehan MJ; Rogers H; Tyers MB; Judd DB; Scopes DI; Naylor A
    Br J Pharmacol; 1990 Dec; 101(4):944-8. PubMed ID: 1964823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
    Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
    Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.